Evidence map›Paper›PMID 26807527›Full record

ArticleNature biotechnology2016

Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates.

Arturo J Vegas, Omid Veiseh, Joshua C Doloff, Minglin Ma, Hok Hei Tam, Kaitlin Bratlie, Jie Li, Andrew R Bader, Erin Langan, Karsten Olejnik and 25 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 233 papers.

0numbers the graph read from it
0cells of the map it votes in
233citing papers in PubMed
53.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

233 citing papers in PubMed, 532 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Biomaterial-EnabledCell biomaterials · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Tissue-bioelectronics interfaces.Chemical Society reviews · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

173 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 6 institutions in 1 country.

Arturo J VegasDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Omid VeisehDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Joshua C DoloffDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Minglin MaDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Hok Hei TamDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Kaitlin BratlieDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-5197-0176
Jie LiDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Andrew R BaderDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Erin LanganDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Karsten OlejnikDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Patrick FentonDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jeon Woong KangMIT Spectroscopy Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jennifer Hollister-LockeSection on Islet Cell and Regenerative Biology, Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA.
Matthew A BochenekDepartment of Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, Illinois, USA.
Alan ChiuDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Sean SiebertDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Katherine TangDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Siddharth JhunjhunwalaDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Stephanie Aresta-DasilvaDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Nimit DholakiaDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Raj ThakrarDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Thema ViettiDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Michael ChenDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-1590-768X
Josh CohenSection on Islet Cell and Regenerative Biology, Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA.
Karolina SiniakowiczSection on Islet Cell and Regenerative Biology, Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA.
Meirigeng QiDepartment of Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, Illinois, USA.
James McGarrigleDepartment of Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, Illinois, USA.
Adam C Graham
Stephen LyleDepartment of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
David M HarlanDiabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Dale L GreinerDiabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Jose OberholzerDepartment of Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, Illinois, USA.
Gordon C WeirSection on Islet Cell and Regenerative Biology, Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA.
Robert LangerDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Daniel G AndersonDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Boston Children's Hospital · USJoslin Diabetes Center · USMassachusetts Institute of Technology · USUniversity of Illinois Chicago · USUniversity of Massachusetts Chan Medical School · USHarvard University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
The Development of Clinical Grade, Targeted Magnetic NanoparticlesU54CA151884 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WEISSLEDER, MD, PHD, RALPH · 2010 to 2014
$11.3M
Wide-Field Short-Wave Infrared (SWIR) multiphoton (MP) tissue imagingP41EB015871 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SO, PETER T. · 2012 to 2021
$11.3M
PHOTOPOLYMERIZATION FOR NONINVASIVE CARTILAGE TISSUER01DE013023 · NIDCR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 1998 to 2019
$6.8M
CONTROLLED RELEASE OF MACROMOLECULESR01EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL, TRAVERSO, CARLO GIOVANNI · 2002 to 2021
$6.1M
Controlled Release of MacromoleculesR37EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2008 to 2017
$3.9M
Ultrasound Polymeric Drug DeliveryR01EB000351 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2002 to 2013
$3.0M
Physiological Factors Driving Maturation of Neonatal Beta CellsR01DK093909 · NIDDK · JOSLIN DIABETES CENTER · PI BONNER-WEIR, SUSAN · 2011 to 2015
$1.8M
Beta Cell Specific Microfluidic Perifusion and Imaging for Islet Potency TestingR01DK091526 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI OBERHOLZER, JOSE · 2011 to 2015
$1.7M
NCI NIH HHS CA151884NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051NCI NIH HHS U54 CA151884NIBIB NIH HHS EB000244NIBIB NIH HHS EB000351NIBIB NIH HHS P41 EB015871NIBIB NIH HHS P41EB015871-27NIBIB NIH HHS R01 EB000244NIBIB NIH HHS R01 EB000351NIBIB NIH HHS R37 EB000244NIDCR NIH HHS DE013023NIDCR NIH HHS R01 DE013023NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30DK036836NIDDK NIH HHS R01 DK091526NIDDK NIH HHS R01DK091526NIDDK NIH HHS R01 DK093909NIDDK NIH HHS R01DK093909
6 · The paper itself

Abstract

The foreign body response is an immune-mediated reaction that can lead to the failure of implanted medical devices and discomfort for the recipient. There is a critical need for biomaterials that overcome this key challenge in the development of medical devices. Here we use a combinatorial approach for covalent chemical modification to generate a large library of variants of one of the most widely used hydrogel biomaterials, alginate. We evaluated the materials in vivo and identified three triazole-containing analogs that substantially reduce foreign body reactions in both rodents and, for at least 6 months, in non-human primates. The distribution of the triazole modification creates a unique hydrogel surface that inhibits recognition by macrophages and fibrous deposition. In addition to the utility of the compounds reported here, our approach may enable the discovery of other materials that mitigate the foreign body response.

Indexed as

AnimalsBiocompatible MaterialsForeign BodiesForeign-Body ReactionHumansHydrogelsMacrophagesPrimatesProstheses and ImplantsBiocompatible MaterialsHydrogels

Identifiers

PMID26807527
PMCPMC4904301
OpenAlexW2260141621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.